UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Stromal lymphocyte infiltration after neoadjuvant chemotherapy is associated with aggressive residual disease and lower disease-free survival in HER2-positive breast cancer

Annals of oncology, 2017-09, Vol.28 (9), p.2233-2240

2017

Volltextzugriff (PDF)

BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy

Breast cancer research and treatment, 2016-10, Vol.159 (3), p.499-511

2016

Volltextzugriff (PDF)

Long-term survival of advanced triple-negative breast cancers with a dose-intense cyclophosphamide/anthracycline neoadjuvant regimen

British journal of cancer, 2014-03, Vol.110 (6), p.1413-1419

2014

Volltextzugriff (PDF)

Cytochrome P-450-mediated herb and food–drug interactions can be identified in cancer patients through patient self-reporting with a tablet application: results of a prospective observational study

ESMO open, 2022-12, Vol.7 (6), p.100650, Article 100650

2022

Volltextzugriff (PDF)

Neoadjuvant treatment: the future of patients with breast cancer

ESMO open, 2018, Vol.3 (4), p.e000371-e000371, Article e000371

2018

Volltextzugriff (PDF)

BI-RADS categorisation of 2708 consecutive nonpalpable breast lesions in patients referred to a dedicated breast care unit

European radiology, 2012, Vol.22 (1), p.9-17

2012

Volltextzugriff (PDF)

Correlation between MRI and biopsies under second look ultrasound

Diagnostic and interventional imaging, 2014-02, Vol.95 (2), p.197-211

2014

Volltextzugriff (PDF)

A multivariate Th17 metagene for prognostic stratification in T cell non-inflamed triple negative breast cancer

Oncoimmunology, 2019-09, Vol.8 (9), p.e1624130-e1624130

2019

Volltextzugriff (PDF)

Biological network-driven gene selection identifies a stromal immune module as a key determinant of triple-negative breast carcinoma prognosis

Oncoimmunology, 2016-01, Vol.5 (1), p.e1061176-e1061176

2016

Volltextzugriff (PDF)

Evolution of contraceptive practices in France: An overview from 2014 to 2019

Gynécologie, obstétrique, fertilité & sénologie, 2022-07, Vol.50 (7-8), p.535-541

2022

Volltextzugriff (PDF)

Techniques and complications of non-genetic risk reducing mastectomies: Guidelines of the National College of French Gynecologists and Obstetricians (CNGOF)

Gynécologie, obstétrique, fertilité & sénologie, 2022-02, Vol.50 (2), p.121-129

2022

Volltextzugriff (PDF)

Prognostic impact of 18F-FDG PET/CT staging and of pathological response to neoadjuvant chemotherapy in triple-negative breast cancer

European journal of nuclear medicine and molecular imaging, 2015-03, Vol.42 (3), p.377-385

2015

Volltextzugriff (PDF)

Prognostic Impact of 18FDG-PET-CT Findings in Clinical Stage III and IIB Breast Cancer

JNCI : Journal of the National Cancer Institute, 2012-12, Vol.104 (24), p.1879-1887

2012

Volltextzugriff (PDF)

Contraception after breast cancer: a retrospective review of the practice among French gynecologists in the 2000's

European journal of gynaecological oncology, 2014, Vol.35 (2), p.149-153

2014

Volltextzugriff (PDF)

O-087 Use and safety of assisted reproductive technology in young BRCA carriers with a pregnancy after treatment for breast cancer: results from an international cohort study

Human reproduction (Oxford), 2024-07, Vol.39 (Supplement_1)

2024

Volltextzugriff (PDF)

Impact de la reconstruction par lipomodelage sur la survie des patientes jeunes ayant un cancer du sein à partir de la cohorte du Système national des données de santé (SNDS)

Journal of Epidemiology and Population Health, 2024-03, Vol.72, p.202376, Article 202376

2024

Volltextzugriff (PDF)

351TiP EORTC BCG 1984 – NOBLE: Noeoadjuvant olaparib and durvalumab for patients with BRCA-associated triple-negative breast cancer

Annals of oncology, 2023-10, Vol.34, p.S322-S322

2023

Volltextzugriff (PDF)

Abstract P3-11-01: Interaction between molecular subtype and stromal immune infiltration dynamics in breast cancer patients treated with neoadjuvant chemotherapy

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P3-P3-11-01

2019

Volltextzugriff (PDF)

Abstract P3-06-11: Withdrawn

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P3-P3-06-11

2018

Volltextzugriff (PDF)

Comedications influence immune infiltration and pathological response to neoadjuvant chemotherapy in breast cancer

Oncoimmunology, 2020-01, Vol.9 (1), p.1677427

2020

Volltextzugriff (PDF)

Prognostic impact of ^sup 18^F-FDG PET/CT staging and of pathological response to neoadjuvant chemotherapy in triple-negative breast cancer

European journal of nuclear medicine and molecular imaging, 2015-03, Vol.42 (3), p.377

2015

Volltextzugriff (PDF)

Abstract P1-14-08: Prediction of pathological response (pCR) to neoadjuvant dose dense and intense cyclophosphamide and anthracycline in a prospective series of triple negative locally advanced breast cancers (TNLABC)

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P1-P1-14-08

2016

Volltextzugriff (PDF)

Abstract P4-13-03: Hormone replacement therapy, is there an increased risk of in situ breast cancer ? data from a french cohort

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P4-P4-13-03

2012

Volltextzugriff (PDF)

Abstract P6-16-02: Fertility preservation in young breast cancer patients: Real life data on 1390 patients treated in the Institut Curie

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P6-P6-16-02

2019

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(58)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Stromal lymphocyte infiltration after neoadjuvant chemotherapy is associated with aggressive residual disease and lower disease-free survival in HER2-positive breast cancer

BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy

Long-term survival of advanced triple-negative breast cancers with a dose-intense cyclophosphamide/anthracycline neoadjuvant regimen

Cytochrome P-450-mediated herb and food–drug interactions can be identified in cancer patients through patient self-reporting with a tablet application: results of a prospective observational study

Neoadjuvant treatment: the future of patients with breast cancer

BI-RADS categorisation of 2708 consecutive nonpalpable breast lesions in patients referred to a dedicated breast care unit

Correlation between MRI and biopsies under second look ultrasound

A multivariate Th17 metagene for prognostic stratification in T cell non-inflamed triple negative breast cancer

Biological network-driven gene selection identifies a stromal immune module as a key determinant of triple-negative breast carcinoma prognosis

Evolution of contraceptive practices in France: An overview from 2014 to 2019

Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancer

Techniques and complications of non-genetic risk reducing mastectomies: Guidelines of the National College of French Gynecologists and Obstetricians (CNGOF)

Prognostic impact of 18F-FDG PET/CT staging and of pathological response to neoadjuvant chemotherapy in triple-negative breast cancer

Prognostic Impact of 18FDG-PET-CT Findings in Clinical Stage III and IIB Breast Cancer

Contraception after breast cancer: a retrospective review of the practice among French gynecologists in the 2000's

O-087 Use and safety of assisted reproductive technology in young BRCA carriers with a pregnancy after treatment for breast cancer: results from an international cohort study

Impact de la reconstruction par lipomodelage sur la survie des patientes jeunes ayant un cancer du sein à partir de la cohorte du Système national des données de santé (SNDS)

351TiP EORTC BCG 1984 – NOBLE: Noeoadjuvant olaparib and durvalumab for patients with BRCA-associated triple-negative breast cancer

Abstract P3-11-01: Interaction between molecular subtype and stromal immune infiltration dynamics in breast cancer patients treated with neoadjuvant chemotherapy

Abstract P3-06-11: Withdrawn

Comedications influence immune infiltration and pathological response to neoadjuvant chemotherapy in breast cancer

Prognostic impact of ^sup 18^F-FDG PET/CT staging and of pathological response to neoadjuvant chemotherapy in triple-negative breast cancer

Abstract P1-14-08: Prediction of pathological response (pCR) to neoadjuvant dose dense and intense cyclophosphamide and anthracycline in a prospective series of triple negative locally advanced breast cancers (TNLABC)

Abstract P4-13-03: Hormone replacement therapy, is there an increased risk of in situ breast cancer ? data from a french cohort

Abstract P6-16-02: Fertility preservation in young breast cancer patients: Real life data on 1390 patients treated in the Institut Curie

Suchergebnisse filtern